Pharma Journalist 9017 posts 0 comments

Novartis announced it is investing in next-generation biotherapeutics with the creation of a fully integrated, dedicated USD 300m scientific environment that will bolster its capacity…
Read More...

Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders,  announced the closing of a $32.7 million financing to support the…
Read More...

Bristol Myers Squibb announced that the U.S. Food and Drug Administration (FDA) approved Sotyktu (deucravacitinib), a first-in-class, oral, selective, allosteric tyrosine kinase 2…
Read More...

Gatehouse Bio, a pioneer in small RNA therapeutics, and AstraZeneca, a global, science-led biopharmaceutical company, are advancing their partnership, to create RNA therapeutics for the…
Read More...

Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, announced that the U.S. Food and Drug…
Read More...

Pfizer Inc. announced that its investigational Group B Streptococcus (GBS) vaccine candidate, GBS6 or PF-06760805, received Breakthrough Therapy Designation from the U.S. Food and Drug…
Read More...

roofPilot and Citeline Connect, the most comprehensive solution for clinical trial engagement and recruitment, announced a strategic partnership to make clinical trials more accessible…
Read More...

Good Therapeutics, a privately held company, announced it has entered into a definitive merger agreement to be acquired by Roche. With this acquisition, Roche will gain rights to Good…
Read More...

Tetra Bio-Pharma Inc. announced they signed an agreement with Cellvera Global Holdings LLC ("Cellvera"), for the co-development of ARDS-003 as a combination product, with Qifenda 400MG…
Read More...

AceLink Therapeutics, Inc. (AceLink), an innovative biopharmaceutical company developing transformative therapies for genetic diseases, announced it has received Orphan Drug Designation…
Read More...